Graf Akcie ADMP (Adamis Pharmaceuticals Corp). Diskuze k akciím ADMP. Aktuální informace ADMP.

Základní informace o společnosti Adamis Pharmaceuticals Corp (Akcie ADMP)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 159.31M
Hodnota podniku (EV) 153.25M
Tržby 16.527M
EBITDA -33.62
Zisk -49.39
Růst v tržbách Q/Q -34.35 %
Růst v tržbách Y/Y -25.26 %
P/E (Cena vůči ziskům) N/A
Forward P/E -0.03
EV/Sales 9.27
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 5.02
P/FCF N/A
Price/Book 48.53
Účetní hodnota na akcii 0.02
Hotovost na akcii 0.05
FCF vůči ceně -21.37 %
Počet zaměstnanců 130
Tržba na zaměstnance 127.134k
Profit margin -298.84 %
Operating margin -225.25 %
Gross margin 9.88 %
EBIT margin -297.86 %
EBITDA margin -203.43 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 200.00 %
EPS - Očekávaný růst příští rok -60.00 %
Return on assets -59.12 %
Return on equity -270.65 %
ROIC -125.09 %
ROCE -449.92 %
Dluhy/Equity 7.83
Čistý dluh/EBITDA 0.39
Current ratio 0.63
Quick Ratio 0.40
Volatilita 5.28
Beta 1.18
RSI 62.84
Cílová cena analytiků 1
Známka akcie (dle analytiků) 3.00
Insider ownership 1.06 %
Institutional ownership 8.41 %
Počet akcií 148.886M
Procento shortovaných akcií 6.47 %
Short ratio 5.41 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2003
Země United States

Finanční výsledky akcie ADMP

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$22.114$15.087$13.073$6.474--
Cost Of Goods Sold$15.479$9.798$7.42$4.854--
Gross Profit$6.635$5.289$5.653$1.62--
Research And Development Expenses$10.376$18.794$7.527$9.697$4.843$3.546
SG&A Expenses$25.288$25.948$22.819$17.128$9.007$4.556
Other Operating Income Or Expenses$-0.322$-0.011$-0.096---
Operating Expenses$51.465$54.55$37.862$31.678$13.85$8.102
Operating Income$-29.351$-39.464$-24.789$-25.204$-13.85$-8.102
Total Non-Operating Income/Expense$0.053$0.088$-1.089$1.192$0.278$-1.215
Pre-Tax Income$-29.298$-39.376$-25.878$-24.012$-13.572$-9.316
Income Taxes$0.009$-0.369$-0.339$-4.575--
Income After Taxes$-29.307$-39.007$-25.539$-19.437$-13.572$-9.316
Other Income------
Income From Continuous Operations$-29.307$-39.007$-25.539$-19.437$-13.572$-9.316
Income From Discontinued Operations------
Net Income$-29.307$-39.007$-25.539$-20.812$-13.572$-9.316
EBITDA$-26.406$-36.365$-21.726$-22.67$-12.86$-6.997
EBIT$-29.351$-39.464$-24.789$-25.204$-13.85$-8.102
Basic Shares Outstanding533928181311
Shares Outstanding533928181311
Basic EPS$-0.55$-1.00$-0.90$-1.19$-1.02$-0.89
EPS - Earnings Per Share$-0.55$-1.00$-0.90$-1.19$-1.03$-0.89
# 2020 2019 2018 2017 2016 2015
Current Ratio1.35922.23172.44230.82111.51091.165
Long-term Debt / Capital--0.06130.1082--
Debt/Equity Ratio0.05970.05530.12810.2926--
Gross Margin30.00435.055243.24325.0281--
Operating Margin-132.7249-261.5808-189.6167-389.3182--
EBIT Margin-132.7249-261.5808-189.6167-389.3182--
EBITDA Margin-119.4097-241.04-166.183-350.1672--
Pre-Tax Profit Margin-132.4874-260.9999-197.9489-370.9005--
Net Profit Margin-132.5266-258.5518-195.3528-321.4636--
Asset Turnover0.46220.25850.25430.1713--
Inventory Turnover Ratio7.512.98814.06675.1521--
Receiveable Turnover11.777413.060215.74928.0385--
Days Sales In Receivables30.991627.947623.175845.4065--
ROE - Return On Equity-81.3236-83.5409-64.578-76.8885-145.7172-98.0356
Return On Tangible Equity-169.7068-150.9515-157.4523912.495-877.2691-1217.277
ROA - Return On Assets-61.2593-66.8405-49.6837-51.4398-112.52-72.2354
ROI - Return On Investment-81.3236-83.5409-60.6186-68.5692-145.7156-98.0342
Book Value Per Share0.58280.98731.18441.14950.69350.8922
Operating Cash Flow Per Share0.4622-0.30170.6753-0.4399-0.16010.2958
Free Cash Flow Per Share0.4988-0.31950.6095-0.4468-0.16010.3087